PASC (N=17) Control (N=13) p value
Age years -median (range) 11 (3-18) 12 (6-15) 0.39
Female gender N (%) 9 (53) 2 (15) 0.0575
Time since COVID-19 Diagnosis (months) 5 (2-11) 3 (2-8) 0.89
Duration of PASC symptoms (months)* 5 (2-11) N/A N/A
COVID-19 Severity N (%) COVID-19 Severity N (%) COVID-19 Severity N (%)
Moderate 17(100) 13(100) N/A
SARS-CoV-2 vaccination 0 0 N/A
Variant of concern N (%) Variant of concern N (%) Variant of concern N (%)
WT 10 (59) 7(54) 1
Alpha 7 (41) 6 (46) 0.8167
PASC Type PASC Type PASC Type
Ongoing COVID-19 0 N/A N/A
Post-acute COVID-19 Syndrome 17 (100) N/A N/A